FDA召回数十种眼药水,因潜在失明风险 2023年10月30日,美国食品药品监督管理局(FDA)官网更新滴眼液产品召回清单,共计包含26种非处方滴眼液,相关品牌包括CVS Health、Leader (Cardinal Health)、Rugby (Cardinal Health)、Rite Aid、Target Up & Up和Velocity Pharma。 F...
与隐形眼镜一起使用:建议隐形眼镜佩戴者在滴注0.75%酚妥拉明滴眼剂之前摘下镜片,并在给药后等待10分钟后再重新戴上隐形眼镜。 参考来源:‘Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydri...
参考来源: Viatris and Ocuphire Pharma announce FDA approval of Ryzumi™ (phentolamine ophthalmic solution) 0.75% eye drops for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylep...
South Moon, Rebright and FivFivGo eye drops are unapproved drugs and should not be available for sale in the U.S. They claim to treat eye conditions such as glaucoma, which is treated with prescription drugs or surgery. Patients who have signs or symptoms of an eye infection should talk...
The notice applies to 27 eye drop products marketed under several store brands, such as CVS Health, Rite Aid, Target Up & Up and Walmart Equate, in addition to the Leader, Rugby and Velocity Pharma brands, the Food and Drug AdministrationsaidFriday. The eye drops may contain bacteria that...
参考来源:‘Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., Tropicamide) Agents’,新闻稿。Via...
EYE DROPS SOLD AT WALMART ADDED TO FDA'S LIST OF POTENTIALLY HARMFUL PRODUCTS Last month, the FDA warned users to avoid certain products under the brands CVS Health, Leader, Rugby, Rite Aid, Target's Up & Up, Velocity Pharma and Equate. ...
The FDA and Alcon Laboratories recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count over fungal contamination.
Patients who are seeking treatmentwith amniotic fluid eye drops need to ask if the FDA has reviewed the treatment, health officials said. The FDA also suggests that patients ask for the FDA-issued investigational new drug application number and the chance to review the FDA communication stating th...
参考来源:'Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., Tropicamide) Agents’,新闻稿。Viat...